Hepatitis A Blogs This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Now, Pharma Takes A Whack At The 340B Program
In the latest effort to curtail the controversial 340B Drug Pricing Program, a coalition of drugmakers, biotechs and pharmacy benefit managers have released a scathing report that criticizes government oversight, warns against skyrocketing growth in the number of participating hospitals and complains that lucrative pricing discounts are being unfairly exploited by both hospitals and some physician practices. “Without concerted efforts to achieve program integrity, the potential for continued program misuse is high,” the report states. “Lack of appropriate oversight and the absence of rules consistent with...
Source: Pharmalot - February 13, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized 340B. GlaxoSmithKline Affordable Care Act Medicaid Source Type: blogs